000 | 01105 a2200325 4500 | ||
---|---|---|---|
005 | 20250518050507.0 | ||
264 | 0 | _c20200403 | |
008 | 202004s 0 0 eng d | ||
022 | _a0392-856X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSolmaz, Dilek | |
245 | 0 | 0 |
_aEvidence that systemic therapies for psoriasis may reduce psoriatic arthritis occurrence. _h[electronic resource] |
260 |
_bClinical and experimental rheumatology _c |
||
300 |
_a257-261 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aArthritis, Psoriatic _xepidemiology |
650 | 0 | 4 | _aBiological Products |
650 | 0 | 4 | _aBiological Therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aPsoriasis _xepidemiology |
650 | 0 | 4 | _aRetrospective Studies |
700 | 1 | _aEhlebracht, Alexa | |
700 | 1 | _aKarsh, Jacob | |
700 | 1 | _aBakirci, Sibel | |
700 | 1 | _aMcGonagle, Dennis | |
700 | 1 | _aAydin, Sibel Z | |
773 | 0 |
_tClinical and experimental rheumatology _gvol. 38 _gno. 2 _gp. 257-261 |
|
999 |
_c29883317 _d29883317 |